Artificial Solutions announces deal with one of the largest Healthcare Providers in the world

Artificial Solutions® (SSME: ASAI), the leading specialist in Conversational AI (CAI), today announced the signing of a three-year licensing agreement with one of the largest single-payer healthcare systems in the world. The deal will allow access to Artificial Solutions SaaS platform, Teneo.

The healthcare institution’s goal is to create complex conversational customer experiences across its digital properties and within its core communication channels. The organisation is aiming to see the deployment of CAI solutions at the end of Q2 2022, with a national roll-out set to take place in the near future.

Per Ottosson, CEO of Artificial Solutions, said:

We’re delighted that one of the most recognizable names in European healthcare has chosen to use Teneo as its primary tool for developing conversational customer experiences. We’re confident that our technology is amongst the best in the world and that our team has created a platform which will support the long-term growth of our customers.

Teneo is a SaaS platform that allows Conversational Design teams to create automated text or voice responses in order to support and communicate with users. With 86 languages and a diverse range of integrations that allows users of the platform to work with the likes of WhatsApp, Slack, Facebook Messenger, SMS, Telegram and a variety of existing CAI platforms, Teneo is amongst the leading technologies in the sector.

Microsoft’s LUIS platform is also integrated with Teneo, while Apple, IBM and Google all use patented technology built by the Artificial Solutions Development team.